Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 31c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.39 -3.23%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of $0.14, $0.31 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $41.54 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Twin Disc (TWIN) Tops Q4 EPS by 16c
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
